Investors
Agios is a biopharmaceutical company passionately committed to applying our scientific leadership in the field of cellular metabolism to transform the lives of patients with cancer and rare genetic disorders of metabolism.
Nasdaq: AGIO
    
IR Contacts
Kendra Adams
Senior Director, Investor & Public Relations
Email: investors@agios.com

Renee Leck
Senior Manager Investor & Public Relations
Email: investors@agios.com